In addition to providing a foundation for good cardiovascular health, Vitamin K2 supplementation in children has been clinically shown to improve bone health.
It is rapidly becoming a well-recognized fact: establishing healthy habits in childhood goes a long way toward long-lasting effects. Results of multi-year studies are backing the assertion that Vitamin K2 plays a vital role in providing that healthy foundation.
NattoPharma has sponsored studies that included children that not only revealed that child populations exhibit the greatest need for Vitamin K2, but also studies exclusively in child populations showed daily supplementation may support bone needs from early childhood throughout entire lifespan.
To find out more about the studies showing the life-long benefits a MenaQ7® taken early in life, please visit http://menaq7.com/health-benefits/childrens-health/.
For further information regarding NattoPharma’s R&D activities, please contact:
VP, Global Development & Regulatory